Search Within

Mark Andrew Dickson

Formats
  1. Journal Article (84)
  2. Meeting Abstract (83)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (169)
  2. Sarcoma Service (169)
  3. Solid Tumor Oncology Division (169)
  4. GSK Faculty (92)
  5. Hematologic Malignancies, Division of (86)
  6. Tow Center for Developmental Oncology (TCDO) (78)

More Groups

People
  1. William Tap (90)
  2. Sandra D'Angelo (83)
  3. Mary Keohan (75)
  4. Mrinal Gounder (69)
  5. Li-Xuan Qin (56)
  6. Ping Chi (54)

More People

Years
  1. 2025 (3)
  2. 2024 (13)
  3. 2023 (13)
  4. 2022 (19)
  5. 2021 (6)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. Clinical Cancer Research (17)
  3. Annals of Oncology (8)
  4. European Journal of Cancer (5)
  5. Nature Communications (5)
  6. The Oncologist (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (75)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (14)
  4. Oxford University Press (13)
  5. Nature Publishing Group (10)
  6. Springer (6)

More Publishers

Results (169)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Harmonization of the upfront osteosarcoma treatment paradigm for adolescents and young adults
    Journal Article

    Daukshus, N. P.; Avutu, V.; Long Sarro, E.; Kinnaman, M. D.; Slotkin, E. K.; Thornton, K.; Dickson, M. A.; Sklarin, N. T.; Tap, W. D.; Glade Bender, J.
    Journal of Adolescent and Young Adult Oncology (2025)

    Fulltext@MSK | Save
  • Fifth subtype of Kaposi sarcoma in HIV-negative MSM: A retrospective single-arm cohort study from a tertiary care center in NYC from 2000 to 2022
    Journal Article

    Morales, A. E.; Benson, G.; Glavan, S.; Giuliano, R.; Dickson, M. A.
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Phase II study of palbociclib in patients with tumors with CDK4 or CDK6 amplification: Results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol Z1C
    Journal Article

    O’Hara, M. H.; Jegede, O.; Dickson, M. A.; DeMichele, A. M.; Piekarz, R.; Gray, R. J.; Wang, V.; McShane, L. M.; Rubinstein, L. V.; Patton, D. R.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A retrospective single-center study of outcomes to immune checkpoint blockade-based therapy in leiomyosarcoma
    Meeting Abstract

    Babatunde, O.; Rosenbaum, E.; Kelly, C. M.; Desir-Camille, R.; Keohan, M. L.; Banks, L.; Avutu, V.; Chan, J.; Reed, D.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Response to treatment with nab-Sirolimus in patients with perivascular epithelioid cell sarcoma of gynecologic or peritoneal origin: Subgroup analysis from AMPECT
    Meeting Abstract

    Herzog, T.; Dockery, L.; Dickson, M.; Ganjoo, K.; Ravi, V.; Ding, L.; Schmid, A.; Palma, N.; Navarro, W.; Wagner, A.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma
    Journal Article

    Movva, S.; Seier, K.; Avutu, V.; Banks, L. B.; Chan, J.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): An open-label, randomised clinical trial
    Journal Article

    Mowery, Y. M.; Ballman, K. V.; Hong, A. M.; Schuetze, S. M.; Wagner, A. J.; Monga, V.; Heise, R. S.; Attia, S.; Choy, E.; Burgess, M. A.; more...
    Lancet (2024)

    Fulltext@MSK | Save